17 research outputs found
Responding to the Challenge of the Dual COVID-19 and Ebola Epidemics in the Democratic Republic of Congo—Priorities for Achieving Control
Abstract. As of June 11, 2020, the Democratic Republic of the Congo (DRC) has reported 4,258 COVID-19 cases with
90 deaths. With other African countries, the DRC faces the challenge of striking a balance between easing public health
lockdown measures to curtail the spread of SARS-CoV-2 and minimizing both economic hardships for large sectors of the
population and negative impacts on health services for other infectious and noninfectious diseases. The DRC recently controlled
its tenth Ebola virus disease (EVD) outbreak, but COVID-19 and a new EVD outbreak beginning on June 1, 2020 in the
northwest ´Equateur Province have added an additional burden to health services. Although the epidemiology and transmission
of EVD and COVID-19 differ, leveraging the public health infrastructures and experiences fromcoordinating the EVD response
to guide the public health response toCOVID-19 is critical. Building on the DRC’s 40 years of experience with 10 previous EVD
outbreaks, we highlight the DRC’s multi-sectoral public health approach to COVID-19, which includes community-based
screening, testing, contact-tracing, risk communication, community engagement, and case management. We also highlight
remaining challenges and discuss the way forward for achieving control of both COVID-19 and EVD in the DRC
Recommended from our members
Responding to the Challenge of the Dual COVID-19 and Ebola Epidemics in the Democratic Republic of Congo-Priorities for Achieving Control.
As of June 11, 2020, the Democratic Republic of the Congo (DRC) has reported 4,258 COVID-19 cases with 90 deaths. With other African countries, the DRC faces the challenge of striking a balance between easing public health lockdown measures to curtail the spread of SARS-CoV-2 and minimizing both economic hardships for large sectors of the population and negative impacts on health services for other infectious and noninfectious diseases. The DRC recently controlled its tenth Ebola virus disease (EVD) outbreak, but COVID-19 and a new EVD outbreak beginning on June 1, 2020 in the northwest Équateur Province have added an additional burden to health services. Although the epidemiology and transmission of EVD and COVID-19 differ, leveraging the public health infrastructures and experiences from coordinating the EVD response to guide the public health response to COVID-19 is critical. Building on the DRCs 40 years of experience with 10 previous EVD outbreaks, we highlight the DRCs multi-sectoral public health approach to COVID-19, which includes community-based screening, testing, contact-tracing, risk communication, community engagement, and case management. We also highlight remaining challenges and discuss the way forward for achieving control of both COVID-19 and EVD in the DRC
The critical need for pooled data on coronavirus disease 2019 in African children : an AFREhealth call for action through multicountry research collaboration
Globally, there are prevailing knowledge gaps in the epidemiology, clinical manifestations, and outcomes of severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) infection among children and adolescents; and these gaps are especially wide in African
countries. The availability of robust age-disaggregated data is a critical first step in improving knowledge on disease burden and
manifestations of coronavirus disease 2019 (COVID-19) among children. Furthermore, it is essential to improve understanding of
SARS-CoV-2 interactions with comorbidities and coinfections such as human immunodeficiency virus (HIV), tuberculosis, malaria, sickle cell disease, and malnutrition, which are highly prevalent among children in sub-Saharan Africa. The African Forum for
Research and Education in Health (AFREhealth) COVID-19 Research Collaboration on Children and Adolescents is conducting
studies across Western, Central, Eastern, and Southern Africa to address existing knowledge gaps. This consortium is expected to
generate key evidence to inform clinical practice and public health policy-making for COVID-19 while concurrently addressing
other major diseases affecting children in African countries.The US National Institutes of Health (NIH)/ Fogarty International Centre (FIC) to the African Forum for Research and Education in Health (AFREhealth).https://academic.oup.com/cidam2022Paediatrics and Child Healt
The colliding epidemics of COVID-19, Ebola, and measles in the Democratic Republic of the Congo
CITATION: Nachega, J. B. et al. 2020. The colliding epidemics of COVID-19, Ebola, and measles in the Democratic Republic of the Congo. Lancet Global Health, doi:10.1016/S2214-109X(20)30281-3.The original publication is available at https://www.thelancet.comENGLISH ABSTRACT: The Democratic Republic of the Congo is facing
major public health challenges due to a confluence
of major outbreaks of Ebola virus disease, measles,
and COVID-19.1–4 The tenth Ebola outbreak in
eastern DR Congo began on Aug 1, 2018, and as of
May 28, 2020, there have been 3406 Ebola virus disease
cases with 2243 deaths. The Ebola virus disease outbreak
was well controlled in northeast DR Congo following
a multisectoral response, but four new confirmed
Ebola cases were detected in northwest DR Congo on
June 1, 2020, and an outbreak response is underway.4
Additionally, the DR Congo has been burdened with
recurrent measles outbreaks: 13 3802 cases in 2011,
88381 cases in 2013, and 311471 cases in 2019.2
The
first confirmed case of COVID-19 in DR Congo was
diagnosed on March 10, 2020, and the government
declared a state of emergency on March 24, 2020. A
national multisectoral response committee instituted
lockdown in the capital, Kinshasa, the epicentre of the
epidemic in DR Congo, in which daily confirmed cases
now average 100. As of June 16, 2020, 4777 COVID-19
cases with 106 deaths have been reported from the DR
Congo.https://www.thelancet.com/pdfs/journals/langlo/PIIS2214-109X(20)30281-3.pdfPublisher's versio
Bivariate analysis of MCQ scores associated with health facility properties.
<p>Bivariate analysis of MCQ scores associated with health facility properties.</p
Characteristics of 680 health facilities, and circumstances of microscopy and malaria RDT use.
<p>TBF Thick blood film; RDT rapid diagnostic test.</p>a<p>besides facilities not specifying the circumstances of use, includes the options: (i) RDT in ward, microscopy in laboratory; (ii) patient follow-up; (iii) person performing the RDT absent; (iv) other.</p>b<p>under the option “other”, 41/47 health facilities indicated themselves to perform RDTs if they were available.</p>c<p>in April 2012.</p
Competence of individual end-users to read and interpret RDT test results expressed as a score on 10.
<p>Competence of individual end-users to read and interpret RDT test results expressed as a score on 10.</p
High SARS-CoV-2 Seroprevalence after Second COVID-19 Wave (October 2020–April 2021), Democratic Republic of the Congo
Serologic surveys are important tools for estimating the true burden of COVID-19 in a given population. After the first wave of SARS-CoV-2 infections, a household-based survey conducted in Kinshasa, Democratic Republic of the Congo, estimated >292 infections going undiagnosed for every laboratory-confirmed case. To ascertain the cumulative population exposure in Kinshasa after the second wave of COVID-19, we conducted a prospective population-based cross-sectional study using a highly sensitive and specific ELISA kit. The survey included 2,560 consenting persons from 585 households; 55% were female and 45% male. The overall population-weighted, test kit–adjusted SARS-CoV-2 seroprevalence was 76.5% (95% CI 74.5%–78.5%). The seroprevalence was 4-fold higher than during the first wave, and positivity was associated with age, household average monthly income, and level of education. Evidence generated from this population-based survey can inform COVID-19 response, especially vaccination campaign strategies in the context of vaccine shortages and hesitancy
COVID-19 preventive social-behavioural practices and exposure to SARS-CoV-2 among residents in the city of Yaounde: Lessons from the early phase of the pandemic in Cameroon
Non-pharmaceutical interventions remain key in mitigating the spread of SARS-CoV-2. We sought to assess COVID-19 preventive, social-behavioural practices, and SARS-CoV-2 exposure through IgG rapid tests. This was a cross-sectional survey among 971 respondents residing in 180 households within the “Cite Verte” health district of Yaounde-Cameroon, from October-November 2020. Using a structured questionnaire, data on SARS-CoV-2 preventive and social behavioural practices were collected, while exposure to SARS-CoV-2 was determined by IgG profiling. p<0.05 was considered statistically significant. Overall, 971 participants were enrolled, among whom 56.5% were females. The age group 15–29 (33.5%) and those with a secondary level of education (44.7%) were most represented. Regarding preventive/social behavioural practices, the least respected measure was "stopped work", 49.1%, while the most respected was "Respect of hygiene rules", 93.8%. Women obeyed preventive measures more than men, with 87.6% vs 81.0% adhering to the lockdown, (p = 0.005) and 95.5% vs 91.7% to hygiene rules (p = 0.017). The age range 45–64 years was the least adherent to the lockdown rule, with 75.2% (38/153), p<0.0001. Only 24.7% (73/295) and 6.1% (59/295) of the symptomatic individuals reported having sought medical consultation and Covid-19 testing respectively. In addition, up to 69.8% (555/795) felt healthcare facilities were high-risk sites for getting infected, p = 0.002. Exposure to SARS-CoV-2 by IgG positivity was 31.1% (302/971), with men recording a higher proportion of viral exposure, 51.0% (154/302), p = 0.021. After adjusting for gender, age, education, and occupation; salaried worker (p = 0.029; OR: 0.29), and trading (p = 0.001; OR: 0.23) least complied with lockdown rule. In this community of Cameroonian residents highly exposed to COVID-19, many perceived healthcare facilities as high-risk zones for SARS-CoV-2 infection and consequently did not seek medical interventions. Thus, in the context of such a pandemic, advocacy on risk communication and community engagement for health-seeking attitudes should preferentially target men and those afraid of pandemics